» Articles » PMID: 17618546

Medical Treatment of Endocarditis

Overview
Date 2007 Jul 10
PMID 17618546
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Infective endocarditis (IE) remains a serious and deadly disease. The incidence, which varies by gender and on the presence of predisposing factors, has not decreased, due in part to the aging population with more healthcare exposures and predisposing risk factors such as prosthetic heart valves and intracardiac devices. The most important aspects of treatment in IE hinge upon early diagnosis, microorganism identification with susceptibility testing, and early initiation of appropriate antibiotic therapy. In addition, echocardiographic imaging is critical for both diagnostic and prognostic purposes. Early evaluation for surgery should be considered. Once a therapeutic strategy is begun, careful attention to the clinical course is necessary to ensure appropriate response to therapy and to identify complications early.

Citing Articles

Prosthetic valve endocarditis due to Actinomyces neuii successfully treated with antibiotic therapy.

Grundmann S, Huebner J, Stuplich J, Koch A, Wu K, Geibel-Zehender A J Clin Microbiol. 2009; 48(3):1008-11.

PMID: 20032249 PMC: 2832417. DOI: 10.1128/JCM.01106-09.

References
1.
Ravindran V, John J, Kaye G, Meigh R . Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy. J Infect. 2003; 47(2):164-6. DOI: 10.1016/s0163-4453(03)00012-4. View

2.
Elliott T, Foweraker J, Gould F, Perry J, Sandoe J . Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2004; 54(6):971-81. DOI: 10.1093/jac/dkh474. View

3.
Lalani T, Kanafani Z, Chu V, Moore L, Corey G, Pappas P . Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis. 2006; 25(6):365-8. DOI: 10.1007/s10096-006-0141-z. View

4.
Sexton D, Tenenbaum M, Wilson W, Steckelberg J, Tice A, Gilbert D . Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis. 1998; 27(6):1470-4. DOI: 10.1086/515038. View

5.
Hogevik H, Olaison L, Andersson R, Lindberg J, ALESTIG K . Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore). 1995; 74(6):324-39. DOI: 10.1097/00005792-199511000-00003. View